scholarly journals TRANSFORMING DEMENTIA SERVICE DELIVERY: THE MENTAL HEALTH GERO-CHAMPIONS PROGRAM

2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. S380-S380
Author(s):  
Regina M Koepp

Abstract In order to provide effective mental health care to older adults with major neurocognitive disorders (e.g., Alzheimer’s disease and related dementias) within outpatient mental health clinics, mental health practitioners must possess a basic understanding of these disorders, the needs of and challenges faced by people living with dementia and their families, and effective treatment approaches for this population. The Mental Health Gero-Champions Program was established in 2015 at a large Veterans Affairs medical center with the aim of providing clinical support and opportunities for training to multidisciplinary mental health providers to enhance skills in assessing and treating older adults with neurocognitive disorders. This presentation will provide an overview of the Mental Health Gero-Champions Program, describe the development and implementation of this program, and discuss challenges and successes in sustaining this transformative initiative over time.

Author(s):  
Bridget T. Doan ◽  
Yue Bo Yang ◽  
Erin Romanchych ◽  
Seena Grewal ◽  
Suneeta Monga ◽  
...  

Abstract COVID-19 restrictions have necessitated child/youth mental health providers to shift towards virtually delivering services to patients’ homes rather than hospitals and community mental health clinics. There is scant guidance available for clinicians on how to address unique considerations for the virtual mental healthcare of children and youth as clinicians rapidly shift their practices away from in-person care in the context of the COVID-19 pandemic. Therefore, we bridge this gap by discussing a six-pillar framework developed at Hospital for Sick Children (SickKids) in Toronto, Ontario, Canada, for delivering direct to patient virtual mental healthcare to children, youth and their families. We also offer a discussion of the advantages, disadvantages, and future implications of such services.


2020 ◽  
Vol 30 (3) ◽  
pp. 423-439
Author(s):  
Christin Mujica ◽  
Kiara Alvarez ◽  
Shalini Tendulkar ◽  
Mario Cruz-Gonzalez ◽  
Margarita Alegría

2020 ◽  
Author(s):  
Rachel Elizabeth Weiskittle ◽  
Michelle Mlinac ◽  
LICSW Nicole Downing

Social distancing measures following the outbreak of COVID-19 have led to a rapid shift to virtual and telephone care. Social workers and mental health providers in VA home-based primary care (HBPC) teams face challenges providing psychosocial support to their homebound, medically complex, socially isolated patient population who are high risk for poor health outcomes related to COVID-19. We developed and disseminated an 8-week telephone or virtual group intervention for front-line HBPC social workers and mental health providers to use with socially isolated, medically complex older adults. The intervention draws on skills from evidence-based psychotherapies for older adults including Acceptance and Commitment Therapy, Cognitive-Behavioral Therapy, and Problem-Solving Therapy. The manual was disseminated to VA HBPC clinicians and geriatrics providers across the United States in March 2020 for expeditious implementation. Eighteen HBPC teams and three VA Primary Care teams reported immediate delivery of a local virtual or telephone group using the manual. In this paper we describe the manual’s development and clinical recommendations for its application across geriatric care settings. Future evaluation will identify ways to meet longer-term social isolation and evolving mental health needs for this patient population as the pandemic continues.


Author(s):  
Mary F. Wyman ◽  
Corrine I. Voils ◽  
Ranak Trivedi ◽  
Lisa Boyle ◽  
Daniel Goldman ◽  
...  

2021 ◽  
pp. appi.ps.2020005
Author(s):  
Deborah M. Layman ◽  
Jamie Kammer ◽  
Emily Leckman-Westin ◽  
Mike Hogan ◽  
Julie Goldstein Grumet ◽  
...  

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. 570-570
Author(s):  
Rachel Weiskittle

Abstract In response to the urgent need for virtual mental health treatments during the COVID-19 pandemic, an 8-week group intervention deliverable over video or telephone was developed and disseminated in March 2020. Manual content addressed social isolation and information related to COVID-19. In August 2020, a national web-based provider feedback survey was disseminated to evaluate feasibility of the manual. Respondents (n = 21) across a variety of geriatric mental health clinics reported this intervention to be effective and clinically useful with their patients in providing social support and in mitigating COVID-19 anxieties. The majority of respondents delivered the group in multiple cohorts and found the manual adaptable beyond the early pandemic period.


2017 ◽  
Author(s):  
◽  
Tammie Gainey

The purpose of this study was to evaluate mental health clinicians' perceived knowledge regarding pharmacogenetic testing; their attitude, receptivity towards, and confidence in pharmacogenetic testing; and how pharmacogenetic testing is being implemented to support decision making in outpatient clinics. This study was guided by Rogers' Diffusion of Innovation (DOI) Theory. An exhausted literature search was conducted to find studies on mental health clinicians' knowledge, perceived attitudes, and implementation of pharmacogenetic testing. The subject population included 28 mental health clinicians who are actively utilizing pharmacogenetic testing in outpatient mental health clinics. Participants responded to semi-structured open-ended prompts regarding knowledge, perceptions and implementation of pharmacogenetic testing in mental health outpatient clinics. Data were analyzed using a qualitative descriptive approach. Five relevant themes emerged related to the perceptions of pharmacogenetic testing, impact on clinical decision-making, associated concerns of pharmacogenetic testing, knowledge gaps among clinicians, and policy challenges. Overall, clinicians perceived pharmacogenetic testing beneficial to guide dosing and medication selection to decrease the risk of side effects and increase tolerability of psychotropic medications. This study will lead to future research to support shared decision-making around pharmacogenetics testing, medication adherence and tolerability, and setting guidelines for pharmacogenetics testing in mental health clinics.


Sign in / Sign up

Export Citation Format

Share Document